Description

Galvus 50mg is an oral antidiabetic medication containing Vildagliptin as the active ingredient. It is used to control blood glucose levels in adults with type 2 diabetes mellitus (T2DM). Vildagliptin works by enhancing the body’s natural ability to regulate blood sugar through the DPP-4 inhibition mechanism, which increases incretin hormone activity, promoting insulin release and reducing glucagon secretion after meals.

Prescription

• Prescription-only medicine

Therapeutic Category

• Antidiabetic agent / DPP-4 inhibitor (Dipeptidyl Peptidase-4 inhibitor)

Active Ingredients/Composition

• Vildagliptin 50 mg per tablet

Excipients (may include):

• Lactose monohydrate

• Magnesium stearate

• Microcrystalline cellulose

• Hypromellose

• Titanium dioxide

• Other standard tablet excipients

Vitamins

• None

Minerals

• None

Variant

• Galvus 50mg tablets – single ingredient (Vildagliptin)

• Galvus Met – combination of Vildagliptin + Metformin (50/500mg, 50/850mg, 50/1000mg) for dual therapy

Consume Type

• Oral (tablet, swallowed with water)

Directions/Usage

• Usual dose: 50 mg once or twice daily, depending on whether it is used alone or in combination with other antidiabetic agents.

• Monotherapy: 50 mg once daily in the morning.

• With other oral antidiabetics (e.g., metformin, sulfonylureas, insulin): 50 mg twice daily (morning and evening).

• Can be taken with or without food.

Always follow your doctor’s instructions.

Common Side Effects

Mild to moderate:

• Headache

• Dizziness

• Constipation

• Nausea

• Mild hypoglycemia (when used with other diabetes drugs)

• Fatigue

Rare but serious:

• Elevated liver enzymes

• Pancreatitis (rare)

• Hypersensitivity reactions (rash, swelling)

• Joint or muscle pain

Package Type

• Blister pack of 14, 28, or 30 tablets (film-coated)

Storage Advice

• Store at room temperature (below 30°C).

• Keep away from moisture and direct sunlight.

• Store in the original package to protect from light and humidity.

Safety Advice

• Prescription required – take only under medical supervision.

• Regularly monitor blood glucose and liver function tests.

• Avoid in patients with severe liver impairment.

• Use with caution in renal impairment.

• Not recommended during pregnancy or breastfeeding unless advised by a doctor.

• Maintain a proper diet and exercise regimen alongside medication.

• Do not double the dose if a tablet is missed — take the next scheduled dose.

Product Substitutes

Equivalent alternatives (brand names may vary by region):

• Zomelis 50mg (Vildagliptin) – by USV Ltd.

• Vildus 50mg – by Abbott

• Vildamet (Vildagliptin + Metformin)

• Vildagliptin tablets by Glenmark, Sun Pharma, or Teva

Manufacturer/Marketer

• Manufacturer: Novartis Pharma AG

• Marketer (varies by region): Novartis Pharmaceuticals, Sandoz, or authorized local distributors.

Country of Origin

• Switzerland